BSE Live
Sep 12, 16:01Prev. Close
3281.85
Open Price
3275.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 12, 15:55Prev. Close
3283.90
Open Price
3286.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3343.90 (741)
Profit & Loss account of Dr Lal PathLabs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 1,273.40 | 1,164.85 | 1,024.01 | 881.88 | 765.40 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 1,273.40 | 1,164.85 | 1,024.01 | 881.88 | 765.40 | |
Total Operating Revenues | 1,273.60 | 1,164.90 | 1,024.04 | 881.88 | 765.40 | |
Other Income | 57.60 | 46.49 | 31.51 | 28.28 | 20.41 | |
Total Revenue | 1,331.20 | 1,211.39 | 1,055.56 | 910.16 | 785.81 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 219.31 | 191.25 | 0.00 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 286.90 | 254.96 | 0.00 | 0.00 | 168.13 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Employee Benefit Expenses | 232.10 | 201.86 | 175.09 | 147.31 | 133.07 | |
Finance Costs | 14.70 | 0.74 | 0.82 | 0.70 | 0.49 | |
Depreciation And Amortisation Expenses | 68.00 | 36.18 | 31.05 | 26.44 | 32.01 | |
Other Expenses | 426.80 | 425.28 | 373.54 | 313.21 | 260.35 | |
Total Expenses | 1,028.50 | 919.03 | 799.80 | 678.90 | 594.05 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 302.70 | 292.37 | 255.76 | 231.26 | 191.75 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 302.70 | 292.37 | 255.76 | 231.26 | 191.75 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 80.20 | 100.54 | 90.87 | 79.50 | 61.03 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -0.70 | -3.62 | -3.38 | -0.73 | 4.34 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.64 | |
Total Tax Expenses | 79.50 | 96.93 | 87.49 | 78.78 | 66.00 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 223.20 | 195.44 | 168.27 | 152.48 | 125.75 | |
Profit/Loss From Continuing Operations | 223.20 | 195.44 | 168.27 | 152.48 | 125.75 | |
Profit/Loss For The Period | 223.20 | 195.44 | 168.27 | 152.48 | 125.75 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 27.09 | 23.74 | 20.54 | 18.76 | 15.31 | |
Diluted EPS (Rs.) | 27.04 | 23.69 | 20.52 | 18.69 | 15.20 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 127.70 | 54.36 | 31.44 | 36.55 | 20.27 | |
Tax On Dividend | 25.70 | 0.00 | 0.00 | 0.00 | 4.13 | |
Equity Dividend Rate (%) | 120.00 | 60.00 | 45.00 | 30.00 | 25.00 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak